asthma in exacerbation is a common occurrence, spontaneous pneumodiastinum is an uncommon condition seen in the paediatric population. Diagnosis, however, may be made by simple radiographic imaging. Management is conservative and geared towards symptomatic relief. No deadly complications rooted from spontaneous pneumomediastinum has been reported. Methods: A total of 269 children with pneumonia and 112 children with non-pulmonary disease were collected from the First Affiliated Hospital of Guangzhou Medical University. The age of them was under 16 years old. Serum levels of KL-6 were detected.
Results: The serum KL-6 level of pneumonia group was higher than the non-pulmonary disease group [170.0(121.0, 272 .0) U/ml vs 119.5 (88.3, 156.0) U/ml], the difference had statistically significant (Z = −.463, P < 0.001). The AUC of the diagnostic test was 0.82 (95% CI: 0.71 to 0.94, P < 0.001), The Youden index of 0.506 was selected as the cutoff point. The sensitivity was 65.50%, the specificity was 92.60%, the accuracy rate was 78.57%, the positive predictive value was 90.48%, and the negative predictive value was 71.43%. The Kappa value was 0.58 [0.37, 0.78]. The serum KL-6 level of severe pneumonia group was higher than the mild to moderate pneumonia group [277.0(204.0,395 .0) U/ml vs 163.5 (116.0,248.8)U/ml], the difference had statistically significant (Z = −.241, P < 0.001). The AUC of diagnostic test was 0.89 (95% CI: 0.81 to 0.96, P < 0.001). The Youden index of 0.452 was selected as the cutoff point. The sensitivity was 93.20%, the specificity was 78.00%, the accuracy rate was 85.88%, the positive predictive value was 82.00%, and the negative predictive value was 91.43%. The Kappa value was 0.72 [0.57, 0.86]. There was no significant difference of KL-6 level among the children with bacterial pneumonia, mycoplasma pneumonia and viral pneumonia.
Conclusion: The serum KL-6 level has certain clinical application value in the diagnosis of paediatric pneumonia and the prediction of severe pneumonia in children, but there is no specificity between different pathogens induced pneumonia. by Burkholderia pseudomallei. Until recent years of 21st century, melioidosis is more considerable because of high mortality rate and difficult therapy. The early diagnosis and bacterial prediction will help to choose appropriate antibiotics and can reduce the mortality. We report some septicaemia, severe pneumonia, acute respiratory failure cases caused by Burkholderia pseudomallei in children admitted to the Children's hospital No 1, HoChiMinh-city, Viet Nam.Determine the epidemiological, clinical, paraclinical and treatment characteristics of pneumonia due to Burkholderia pseudomallei and status of antibiotic susceptibility of Burkholderia pseudomallei to antibiotics recommended for treatment.
Methods: Case series
Results: There were 6 patients ( 4 males, 2 females) (median age: 60 months).The definitive diagnosis were confirmed by lung infiltrations on the chest radiographies and the positive blood or body fluids of Burkholderia pseudomallei. 4/6 children were under 2 years old. Almost were hospitalized in rainy season. Three children came from Cambodia. One cases had underlying disease (beta thalassemia)..All 6 cases had typical clinical presentation of acute pneumonia ,5/6 cases had respiratory failure. 5/6 children (83.3%) had septicaemia. Other clinical appearances included skin abscesses (40%), soft tissue abscesses (60%), and septic arthritis (16.7%).The chest radiographies findings vary widely: nodepatchy consolidation (6/6 cases), and especially pneumatocele (4/6 cases), pleural effusion (almost right lung) (6/6 cases), fibrosis (1/6 cases). Necrotizing pneumonia was found in 3/6 children. Burkholderia pseudomallei were completely sensitive to ceftazidime and TMP-SMX.
Two cases were sensitive to ciprofloxacin, ticarcilin, cefotaxim, carbapenem. Especially, the resistance to carbapeneme were found in 4/6 children. These children had a prolonged hospital stay: median LOS were 27 days . Commonly used antibiotics: ciprofloxacin, ceftazidime, meronem, imipenem, TMP-SMX. One case relapsed of this disease without subsequent eradication therapy (TMP-SMX). During hospitalization, 33% of the patients died (2/6 cases).
Conclusion:
Melioidosis represent an important cause of morbidity, mortality, and fatal community-acquired bacteremic pneumonia. 
